Risk Of Cardiovascular Mortality Secondary To Androgen Deprivation Therapy For Localized Prostate Cancer

UroToday.com - Androgen deprivation therapy (ADT) is associated with metabolic syndrome, which includes the development of type II diabetes mellitus and coronary artery disease. In the October 17, 2007 issue of the Journal of the National Cancer Institute evaluated whether ADT induced metabolic changes result in an increased risk of cardiovascular (CV) death. The longitudinal, observational prostate cancer registry CaPSURE was used to study a cohort of 4,892 men.

More: continued here

Filed under: Cardiovascular on January 13th, 2008